Article Dans Une Revue Nature Communications Année : 2017

Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy

Caroline C. Le Guiner
Marie Montus
  • Fonction : Auteur
  • PersonId : 1514157
Alberto Malerba
  • Fonction : Auteur
Taeyoung Koo
  • Fonction : Auteur
Jean-Laurent Thibaut
  • Fonction : Auteur
Stéphane Blot
Samia Martin
  • Fonction : Auteur
  • PersonId : 938057
Philippe Veron
Christophe Georger
Carole Masurier
  • Fonction : Auteur
  • PersonId : 858686
  • IdRef : 164593748
Federico Mingozzi
Bernard Gjata
  • Fonction : Auteur
  • PersonId : 1513620
  • IdRef : 278863582
Jean-Yves Hogrel
Fulvio Mavilio
Laurent Thibaut
  • Fonction : Auteur

Résumé

Duchenne muscular dystrophy (DMD) is an incurable X-linked muscle-wasting disease caused by mutations in the dystrophin gene. Gene therapy using highly functional microdystrophin genes and recombinant adeno-associated virus (rAAV) vectors is an attractive strategy to treat DMD. Here we show that locoregional and systemic delivery of a rAAV2/8 vector expressing a canine microdystrophin (cMD1) is effective in restoring dystrophin expression and stabilizing clinical symptoms in studies performed on a total of 12 treated golden retriever muscular dystrophy (GRMD) dogs. Locoregional delivery induces high levels of microdystrophin expression in limb musculature and significant amelioration of histological and functional parameters. Systemic intravenous administration without immunosuppression results in significant and sustained levels of microdystrophin in skeletal muscles and reduces dystrophic symptoms for over 2 years. No toxicity or adverse immune consequences of vector administration are observed. These studies indicate safety and efficacy of systemic rAAV-cMD1 delivery in a large animal model of DMD, and pave the way towards clinical trials of rAAV-microdystrophin gene therapy in DMD patients.

Fichier principal
Vignette du fichier
Le Guiner 2017_1.pdf (2.15 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence
Loading...

Dates et versions

hal-02179396 , version 1 (26-05-2020)

Licence

Identifiants

Citer

Caroline C. Le Guiner, Laurent Servais, Marie Montus, Thibaut Thibaut, Bodvael Fraysse, et al.. Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy. Nature Communications, 2017, 8 (1), pp.16105. ⟨10.1038/ncomms16105⟩. ⟨hal-02179396⟩
1042 Consultations
481 Téléchargements

Altmetric

Partager

  • More